Genome-Wide Identification of Genes Conferring Energy Related Resistance to a Synthetic Antimicrobial Peptide (Bac8c)

PLoS ONE

Volumn 8, Issue 1, 2013, Pages

  Spindler, Eileen C ^a,c   Boyle, Nanette R ^a   Hancock, Robert E W ^b   Gill, Ryan T ^a  

^a UNIVERSITY OF COLORADO   (United States)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c OPX Biotechnologies Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARGINYLISOLEUCYLTRYPTOPHYLVALYLISOLEUCYLTRYPTOPHYLARGINYLARGININE AMIDE; CARBENICILLIN; CARBONYL CYANIDE CHLOROPHENYLHYDRAZONE; GRAMICIDIN; HYDROGEN PEROXIDE; K24 PEPTIDE; PARAQUAT; POLYMYXIN B; POLYPEPTIDE ANTIBIOTIC AGENT; STREPTOMYCIN; SUB3 PEPTIDE; UNCLASSIFIED DRUG; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GENOME; CONTROLLED STUDY; ESCHERICHIA COLI; GENE IDENTIFICATION; GENE LIBRARY; GENE MAPPING; GENE OVEREXPRESSION; GENETIC ALGORITHM; NONHUMAN;

AMINO ACID SEQUENCE; ANTI-INFECTIVE AGENTS; DRUG RESISTANCE, BACTERIAL; ENERGY METABOLISM; ESCHERICHIA COLI; GENOMICS; OLIGOPEPTIDES;

EID: 84873122600     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0055052     Document Type: Article

References (30)

1. Hancock REW, Chapple DS, (1999) Peptide Antibiotics. Antimicrob Agents Chemother 43: 1317-1323.
2. Brogden KA, (2005) Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria? Nat Rev Micro 3: 238-250.
3. Hale JD, Hancock RE, (2007) Alternative mechanisms of action of cationic antimicrobial peptides on bacteria. Expert Review of Anti-Infective Therapy 5: 951-959.
4. Bodanszky M, Perlman D, (1969) Peptide Antibiotics. Science 163: 352-358.
5. Brown KL, Hancock REW, (2006) Cationic host defense (antimicrobial) peptides. Current Opinion in Immunology 18: 24-30.
6. Friedrich CL, Moyles D, Beveridge TJ, Hancock REW, (2000) Antibacterial Action of Structurally Diverse Cationic Peptides on Gram-Positive Bacteria. Antimicrob Agents Chemother 44: 2086-2092.
7. Mangoni ML, Papo N, Barra D, Simmaco M, Bozzi A, et al. (2004) Effects of the antimicrobial peptide temporin L on cell morphology, membrane permeability and viability of Escherichia coli. Biochem J 380: 859-865.
8. Hilpert K, Volkmer-Engert R, Walter T, Hancock REW, (2005) High-throughput generation of small antibacterial peptides with improved activity. Nat Biotech 23: 1008-1012.
9. Wu M, Hancock REW, (1999) Improved Derivatives of Bactenecin, a Cyclic Dodecameric Antimicrobial Cationic Peptide. Antimicrob Agents Chemother 43: 1274-1276.
10. Spindler EC, Hale JDF, Giddings TH, Hancock REW, Gill RT, (2011) Deciphering the Mode of Action of the Synthetic Antimicrobial Peptide Bac8c. Antimicrobial Agents and Chemotherapy 55: 1706-1716.
11. Bonomo J, Lynch MD, Warnecke T, Price JV, Gill RT, (2008) Genome-scale analysis of anti-metabolite directed strain engineering. Metabolic Engineering 10: 109-120.
12. Gill RT, Wildt S, Yang YT, Ziesman S, Stephanopoulos G, (2002) Genome-wide screening for trait conferring genes using DNA microarrays. Proceedings of the National Academy of Sciences of the United States of America 99: 7033-7038.
13. Lynch MD, Warnecke T, Gill RT, (2007) SCALEs: multiscale analysis of library enrichment. Nature Methods 4: 87-93.
14. Warnecke TE, Lynch MD, Karimpour-Fard A, Lipscomb ML, Handke P, et al. (2010) Rapid dissection of a complex phenotype through genomic-scale mapping of fitness altering genes. Metabolic Engineering 12: 241-250.
15. Gall S, Lynch MD, Sandoval NR, Gill RT, (2008) Parallel mapping of genotypes to phenotypes contributing to overall biological fitness. Metabolic Engineering 10: 382-393.
16. Warnecke TE, Lynch MD, Karimpour-Fard A, Sandoval N, Gill RT, (2008) A genomics approach to improve the analysis and design of strain selections. Metabolic Engineering 10: 154-165.
17. Pathania R, Zlitni S, Barker C, Das R, Gerritsma DA, et al. (2009) Chemical genomics in Escherichia coli identifies an inhibitor of bacterial lipoprotein targeting. Nat Chem Biol 5: 849-856.
18. Neidhardt F, (1974) Culture medium for enterobacteria. J Bacteriol 119: 736-747.
19. Sambrook J, Russel DW (2001) Protocol 26: Transformation of E. coli by Electroporation. Molecular Cloning: A Laboratory Manual Cold Spring Harbor Cold Spring Harbor Laboratory Press. 1.119-111.122.
20. Sambrook J, Russel DW (2001) Chapter 13: Mutagenesis. Molecular Cloning: A Laboratory Manual Cold Springs Harbor: Cold Springs Harbor Press. 13.90.
21. Wiegand I, Hilpert K, Hancock REW, (2008) Agar and broth dilution methods to determine the minimal inhibitory concentration (MIC) of antimicrobial substances. Nat Protocols 3: 163-175.
22. Lynch MD, Gill RT, Stephanopoulos G, (2004) Mapping phenotypic landscapes using DNA micro-arrays. Metabolic Engineering 6: 177-185.
23. Ito A, Taniuchi A, May T, Kawata K, Okabe S, (2009) Increased Antibiotic Resistance of Escherichia coli in Mature Biofilms. Applied and Environmental Microbiology 75: 4093-4100.
24. Cloete TE, (2003) Resistance mechanisms of bacteria to antimicrobial compounds. International Biodeterioration and Biodegradation 51: 277-282.
25. Kohanski MA, Dwyer DJ, Hayete B, Lawrence CA, Collins JJ, (2007) A Common Mechanism of Cellular Death Induced by Bactericidal Antibiotics. Cell 130: 797-810.
26. Heitkamp M, Brown OR, (1981) Inhibition of NAD biosynthesis by paraquat in Escherichia coli. Biochimica et Biophysica Acta (BBA)- General Subjects 676: 345-349.
27. Krulwich TA, Quirk PG, Guffanti AA, (1990) Uncoupler-resistant mutants of bacteria. Microbiol Mol Biol Rev 54: 52-65.
28. Fernández L, Breidenstein EBM, Hancock REW, (2011) Creeping baselines and adaptive resistance to antibiotics. Drug Resistance Updates 14: 1-21.
29. Andersson DI, Hughes D, (2010) Antibiotic resistance and its cost: is it possible to reverse resistance? Nat Rev Micro 8: 260-271.
30. Hancock REW (2010) Introduction to the Theme: Seeking Clarity for Membrane-active Peptides. In: Castanho M, editor. Membrane-active peptides: Methods and Results on Structure and Function. La Jolla: International University Line. 3-9.